Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-37.45%
↑ 34% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-57.16%
Historical baseline
PeriodValue
2025-37.45%
2024-56.04%
2023-20.53%
2022-27.22%
2021-158.41%
2020-253.60%
2019-213.66%
2018-101.19%
20173.14%
2016293.37%